Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump BioSpaceAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy...Read full story pharminent July 9, 2026 (Last updated: July 9, 2026) BioSpace An unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy… Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA Warning Letter Hits Sanofi’s Genzyme Ireland SiteNext: Keenova eyes Xiaflex as first drug for plantar fibromatosis Related Stories Regulatory EC approves AbbVie’s Tepkinly combination for follicular lymphoma pharminent July 7, 2026 Regulatory Novartis receives European Commission approval for Itvisma for spinal muscular atrophy pharminent July 2, 2026 Regulatory Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program pharminent July 1, 2026
